Vitaeris has a total of 140 patents globally, out of which 106 have been granted. Of these 140 patents, more than 58% patents are active. United States of America is where Vitaeris has filed the maximum number of patents, followed by Australia and Japan. Parallelly, USA seems to be the main focused R&D centre and also is the origin country of Vitaeris.
Vitaeris founded in 2016, Vitaeris is a biotechnology company focused on advancing treatments for chronic inflammatory diseases. The company holds exclusive global rights to Clazakizumab, a best-in-class anti-interleukin-6 monoclonal antibody, licensed from Alder Biopharmaceuticals. Vitaeris is dedicated to developing innovative therapeutic applications across healthcare and pharmaceutical domains.
Do read about some of the most popular patents of Vitaeris which have been covered by us in this article and also you can find Vitaeris patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Vitaeris patent portfolio.
How many patents does Vitaeris have?
Vitaeris has a total of 140 patents globally. These patents belong to 7 unique patent families. Out of 140 patents, 81 patents are active.
How Many Patents did Vitaeris File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
| Year of Patents Filing or Grant | Vitaeris Applications Filed | Vitaeris Patents Granted |
| 2023 | 2 | 1 |
| 2021 | 7 | 7 |
| 2020 | 3 | 9 |
| 2019 | 15 | 10 |
| 2018 | 7 | 16 |
| 2017 | 12 | 15 |
| 2016 | 5 | 20 |
| 2015 | 15 | 9 |
| 2014 | 2 | 2 |
| 2013 | 4 | 6 |
How many Vitaeris patents are Alive/Dead?
Worldwide Patents
How Many Patents did Vitaeris File in Different Countries?
Countries in which Vitaeris Filed Patents
| Country | Patents |
| United States of America | 74 |
| Australia | 9 |
| Japan | 9 |
| China | 8 |
| Germany | 5 |
| Canada | 4 |
| Europe (EPO) | 3 |
| Hong Kong (S.A.R.) | 3 |
| Taiwan | 3 |
| Austria | 3 |
| Israel | 3 |
| New Zealand | 3 |
| Denmark | 2 |
| Norway | 2 |
| Korea (South) | 2 |
| South Africa | 1 |
| Italy | 1 |
| Spain | 1 |
| Brazil | 1 |
| Hungary | 1 |
Where are Research Centres of Vitaeris Patents Located?
10 Best Vitaeris Patents
US7935340B2 is the most popular patent in the Vitaeris portfolio. It has received 194 citations so far from companies like Alder Biopharmaceuticals, Kite Pharma and H Lundbeck As.
Below is the list of 10 most cited patents of Vitaeris:
| Publication Number | Citation Count |
| US7935340B2 | 194 |
| US8323649B2 | 58 |
| US7906117B2 | 58 |
| US8062864B2 | 57 |
| US8277804B2 | 56 |
| US8178101B2 | 51 |
| US8337847B2 | 51 |
| US8252286B2 | 48 |
| US8404235B2 | 33 |
| US8420089B2 | 32 |
What Percentage of Vitaeris US Patent Applications were Granted?
Vitaeris (Excluding its subsidiaries) has filed 74 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 57 have been granted leading to a grant rate of 79.17%.
Below are the key stats of Vitaeris patent prosecution at the USPTO.
Which Law Firms are managing US Patents for Vitaeris?
| Law Firm | Total Applications | Success Rate |
| Baker Donelson | 60 | 90.15% |
| Hunton Andrews Kurth Llp | 7 | 100.00% |
| Mcneill Pllc | 6 | 50.00% |
| Aristocrat Technologies Inc | 1 | 100.00% |
What are Vitaeris key innovation segments?
What Technologies are Covered by Vitaeris?
The chart below distributes patents filed by Vitaeris in different countries on the basis of the technology protected in patents. It also represents the markets where Vitaeris thinks it’s important to protect particular technological inventions.
R&D Focus: How has Vitaeris search focus changed over the years?
EXCLUSIVE INSIGHTS COMING SOON!
Interested in knowing about the areas of innovation that are being protected by Vitaeris?
